Fremanezumab is a humanized monoclonal antibody that targets human calcitonin gene-related peptide (CGRP). It is used to prevent migraine headaches.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.
Lab / Company